Virtual Reality exposure therapy for public speaking anxiety in routine care: a single-subject effectiveness trial

Virtual Reality (VR) can be used as a therapeutic tool to conduct efficacious in-session exposure therapy by presenting virtual equivalents of phobic stimuli, yet past hardware restrictions hindered implementation in routine care and effectiveness studies. The current study examines the effectivenes...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cognitive behaviour therapy Ročník 50; číslo 1; s. 67 - 87
Hlavní autoři: Lindner, Philip, Dagöö, Jesper, Hamilton, William, Miloff, Alexander, Andersson, Gerhard, Schill, Andreas, Carlbring, Per
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Routledge 2021
Taylor & Francis Ltd
Témata:
Anxiety
Effectiveness
Efficacy
Exposure therapy
Fear of public speaking
Glossophobia
Medical treatment
Psychological distress
Psychology
psykologi
Public speaking
Self evaluation
Therapy
Treatment outcomes
Virtual Reality
effectiveness
exposure therapy
Fear of public speaking
Glossophobia
Virtual Reality
ISSN:1650-6073, 1651-2316, 1651-2316
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Virtual Reality (VR) can be used as a therapeutic tool to conduct efficacious in-session exposure therapy by presenting virtual equivalents of phobic stimuli, yet past hardware restrictions hindered implementation in routine care and effectiveness studies. The current study examines the effectiveness of a VR-assisted treatment protocol for public speaking anxiety with demonstrated efficacy, this time in routine care, using affordable VR hardware. Participants (n = 23) were recruited via a private clinic and treated by one of four psychologists with only minimal VR-training. Using a single-subject design and dual-slope modeling (adjusting the treatment-onset slope for treatment effects), we found a significant, large decrease in self-rated public speaking anxiety following the primary three-hour session, similar in magnitude to the previous efficacy trial. Multilevel modeling of in-session process measures suggests that the protocol works as intended, by decreasing catastrophic belief expectancy and distress, and increasing perceived performance quality. Adherence to the online transition program that followed-encouraging in-vivo exposure-was relatively poor, yet symptoms decrease continued. No change was observed over the three-month follow-up period. We conclude that VR exposure therapy can be effective under routine care conditions and is an attractive approach for future, large-scale implementation and effectiveness trials.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:1650-6073
1651-2316
1651-2316
DOI:10.1080/16506073.2020.1795240